API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while revenue grew 10% to Rs 1,754 crore. Ebitda turned positive at Rs 39.3 crore. The company also became debt-free after repaying Rs 1,050 crore.
API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while revenue grew 10% to Rs 1,754 crore. Ebitda turned positive at Rs 39.3 crore. The company also became debt-free after repaying Rs 1,050 crore.
<iframe src="https://hindustansphere.com/embed/cluster/8b5e3f292618dcef75d5c9ecde185fb049b0545c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Pharmeasy-parent’s loss narrows in Q1, revenue up 10%"></iframe>
